ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-PO711

Increased Monocyte-to-High-Density Lipoprotein Ratio Is Associated with Recurrent Vascular Access Stenosis

Session Information

Category: Dialysis

  • 704 Dialysis: Vascular Access


  • Kim, Yaeni, Incheon St. Mary's Hosp, Catholic Univ of Korea, Incheon, SEoul, Korea (the Republic of)
  • Yoon, Hye Eun, The Catholic University of Korea, Incheon, INCHEON, Korea (the Republic of)
  • Shin, Seok Joon, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon, Incheon, Korea (the Republic of)

Previous studies indicate that increased monocyte count and decreased high-density lipoprotein (HDL) cholesterol levels are associated with chronic kidney disease, and increased risk for cardiovascular diseases, indicating its possible role in pro-inflammatory and pro-oxidant states. We tried to investigate the clinical significance of circulating monocyte count-to-serum HDL cholesterol ratio (M/H ratio) in predicting recurrent vascular access stenosis after angioplasty in hemodialysis patients.


M/H ratio at access creation and prior to angioplasty was measured in a total of one-hundred and fifty hemodialysis patients in Incheon St. Mary’s hospital from July, 2006 to September, 2017. The impact of M/H ratio in predicting recurrent access stenosis was evaluated retrospectively by using Kaplan-Meier, Cox regression, and ROC curve analyses.


The patient group comprised of 67% male and 58% diabetes, aged 62±14 years old (n=150). Baseline M/H ratio at access creation was not different between those with vascular access stenosis (n=71) and those without stenosis (n=79) (10.74 vs. 12.42, p = 0.11). Among patients with vascular access stenosis, there also was no difference in baseline M/H ratios between those with recurrent stenosis (n=33) and those without recurrence (n=38) (9.98 vs. 11.4, p = 0.24). However, pre-angioplasty M/H ratio increased significantly when compared to that of baseline (10.75 vs. 17.95, p < 0.001). Delta M/H ratio, as defined by a difference between baseline and pre-angioplasty ratios was calculated and mean delta M/H ratio was 1.9. Increased delta M/H ratio (delta M/H ratio greater than or equal to 1.9) was associated with recurrent stenosis (HR 4.16, CI 1.43-12.12, p = 0.009). Moreover, increased delta M/H ratio was clinically significant in predicting recurrent vascular access stenosis (AUC 74%, p = 0.001).


Increased delta M/H ratio may play a role in pro-inflammatory and pro-oxidant environment and predispose vascular access for recurrent stenosis after angioplasty.